Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Hospital Acquired Pneumonia (HAP). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Medical Microbiology Testing Technologies Market (Indication: Respiratory Diseases, Neurological Diseases, Infectious Diseases, and Others; and Technology: Cell Culture, Microscopy, and Serology) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Technologies Market – Scope of Report TMR’s report on the global medical microbiology testing technologies market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators ... Read More
-
Viral Vector Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Adenoviral Vectors, Aden-associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Others), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), By Application (Gene Therapy, Vaccinology), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Viral Vector Manufacturing market size is poised to register 13.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Specialty Injectable Generics Market Size, Trends, Analysis, and Outlook By Type (Drugs, Biologics), By Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others), by Country, Segment, and Companies, 2024-2032
... Generics market size is poised to register 8.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Specialty Injectable Generics market across By ... Read More
-
RNA Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Others), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Others), By End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032
... End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032 The global RNA Therapeutics market size is poised to register 8.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating ... Read More
-
Cell and Gene Therapy Manufacturing Services Market Size, Trends, Analysis, and Outlook By Type (Cell Therapy, Gene Therapy), By Indication (Oncology, Cardiovascular, Orthopedic, Ophthalmology, Central Nervous System, Infectious Diseases, Others), By Application (Clinical Manufacturing, Commercial Manufacturing), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Manufacturing), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Cell and Gene Therapy Manufacturing Services market size is poised to register 22.3% growth from ... Read More
-
Vaccine Adjuvants Market Size, Trends, Analysis, and Outlook By Product (Adjuvant Emulsions, Pathogen Components, Saponin-based adjuvants, Particulate Adjuvants, Others), By Route of Administration (Intramuscular, Subcutaneous, Others), By Disease (Infectious Diseases, Cancer, Others), By Application (Research Applications, Commercial Applications), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), by Country, Segment, and Companies, 2024-2032
... Applications, Commercial Applications), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), by Country, Segment, and Companies, 2024-2032 The global Vaccine Adjuvants market size is poised to register 13.7% growth from 2024 to 2032, presenting significant ... Read More
-
Viral Vector and Plasmid DNA Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Viral Vectors, Plasmid DNA), By Products and Services (Product, Services), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Cell and Gene Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Viral Vector and Plasmid ... Read More
-
Infectious Disease Drugs Market Size, Trends, Analysis, and Outlook By Disease (HIV, Influenza, Hepatitis, Tuberculosis, Malaria, Others), By Treatment (Antibacterial, Antiviral, Antiparasitic, Others), by Country, Segment, and Companies, 2024-2032
... size is poised to register 7.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Infectious Disease Drugs market across By Disease (HIV, ... Read More
-
Point of Care Infectious Disease Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology
... and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is ... Read More
-
Global Immunodiagnostics Market Size Study & Forecast, by Product (Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases, Others), By End user (Clinical Laboratories, Hospitals, Physician’s Offices, Others), and Regional Analysis, 2023-2030
... and Regional Analysis, 2023-2030 Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2023-2030. Immunodiagnostics ... Read More
-
Global Artificial Intelligence (Ai) In Epidemiology Market Forecast 2024-2032
... facilitating the market’s growth include the early detection and surveillance of disease outbreaks, the growing need for predictive modeling to forecast disease trends, and data availability for epidemiological research. MARKET INSIGHTS Early detection and surveillance ... Read More
-
Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
H3N2 infection - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Personalized Medicine Market Report by Product (Personalized Medicine Therapeutics, Personalized Medicine Diagnostics, Personalized Medical Care, and Personalized Nutrition and Wellness), Application (Oncology, Infectious disease, Neurology or Psychiatry, Cardiovascular, and Others), End-Users (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others), Region and Company Analysis 2024-2032
... & Academic Institutes, and Others), Region and Company Analysis 2024-2032 The global personalized medicine market was worth US$ 511.09 billion in 2023 and is expected to grow at a CAGR of 7.02% from 2024 to ... Read More
-
Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) - Pipeline Insight, 2024
... development scenario and growth prospects across the Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) market. A detailed picture of the Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) pipeline landscape is provided, which includes the disease overview and ... Read More
-
In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Global Forecast to 2029
... diagnostics market is projected to reach USD 119.4 billion by 2029 from USD 85.2 billion in 2024, at a CAGR of 6.9% during the forecast period. With the rapid growth in the geriatric population globally, ... Read More
-
Global Pneumonia Vaccine Market Growth 2024-2030
... Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Pneumonia Vaccine market. Pneumonia Vaccine ... Read More
-
2024 Global Forecast for Microneedle Flu Vaccine Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Measles, Mumps And Rubella (Mmr) Vaccines Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
RNAi Drug Delivery Market Size, Trends, Analysis, and Outlook By Technology (Nanoparticle drug delivery, Pulmonary drug delivery, Nucleic acid drug delivery, Aptamer drug delivery), By Application (Infectious diseases, Oncology, Cardiology, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global RNAi Drug Delivery market size is poised to register 17.5% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Pneumonia Testing Market Size, Trends, Analysis, and Outlook By Product (Consumable, Analyzer), By Method, Immunodiagnostic, Molecular Diagnostic, Point-of-Care (POC) Testing), By Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluroscence, Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), Others), By End-User (Hospitals, Diagnostic Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... End-User (Hospitals, Diagnostic Centers, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Pneumonia Testing market size is poised to register 5.87% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Infectious Disease Therapeutics Market Assessment, By Mode of Treatment [Vaccines, Drugs], By Infection Type [Viral Infection, Bacterial Infection, Fungal Infection, Parasitic Infection, Others], By Route of Administration [Oral, Parenteral, Others], By Diagnostic Technique [Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing, Next Generation Sequencing, DNA Microarray, Others], By End-user [Hospitals, Diagnostic Centres, Retail Pharmacy, Others], By Region, Opportunities and Forecast, 2017-2031F
... Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing, Next Generation Sequencing, DNA Microarray, Others], By End-user [Hospitals, Diagnostic Centres, Retail Pharmacy, Others], By Region, Opportunities and Forecast, 2017-2031F Global infectious disease therapeutics ... Read More
-
2024 Israel Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
... and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma ... Read More
-
2024 Panama Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
... and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma ... Read More